Patient P-01560

Synthetic patientNBL-101 · Day 114 · 25–34 · M · baseline S19Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Deteriorating

GI state

Favorable

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

28%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S19
Day 31 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 31.

Primary contributors, last 14 days

Toxicity+14
Inflammatory activity+6
Nutritional resilience-5
Treatment adherence-4
GI instability-3

What helped?

No interventions yet.

LIFE OS recommendation

Dietary Support Protocol NP-02

62%

probability of meaningful tolerance improvement

284 similar trajectories
100% showed improvement
median effect visible after 10 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

36.7/100

improving · -2.8 vs previous 14 d

Toxicity

Blood

33.7/100

worsening · +6.7 vs previous 14 d

Sleep quality

Wearable

61.4/100

stable · +0.3 vs previous 14 d

Energy level

Daily log

5.8/10

improving · +0.3 vs previous 14 d

Stress level

Daily log

6.5/10

worsening · +0.2 vs previous 14 d

Steps

Wearable

7,070

stable · +239 vs previous 14 d

Adherence

Companion

94.8 %

worsening · -5.8 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 55 from the failing basin, 32 from restoration.

Would help

NP-02 Dietary Support Protocol
74% improved among 23 similar · onset 10 d · confidence 50%

Would not help

HY-01 Hydration Protocol
only 33% improved among 9 similar

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
-1.8no signal · 33%
Histamine load
-1.7no signal · 26%
Dietary fat load
-1no signal · 15%
Simple carbohydrates
-0.9no signal · 15%
Spicy / capsaicin
-0.5no signal · 15%
Insoluble fibre
+0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↑65
- DNAIL6 -174 variant raises baseline inflammatory tone
- BloodInflammatory load index 43
- WearableHRV 25 ms, trending down
Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Autonomic recovery ↓25
- WearableResting HR 76 bpm

DNA

Fictional pharmacogenomic panel

IL6 -174 G/C
Higher inflammatory tone
CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 4 · butyrate capacity 72/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 27 ms
Sleep: 7.6 h
Steps: 7,072
Resting HR: 72 bpm

Daily log: GI score 37, nutritional resilience 50, adherence 95.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01804	50%	S19	AD-05	improved	61
P-01541	28%	S09	AD-05	no change	43
P-01377	27%	S11	AD-05	no change	42
P-01483	26%	S14	AD-05	no change	35
P-01679	26%	S12	AD-05	no change	39
P-01689	29%	S13	BR-03	no change	50
P-01350	27%	S19	BR-03	no change	34
P-01329	26%	S08	BR-03	improved	79
P-01430	39%	S05	CR-01	improved	54
P-01371	33%	S06	CR-01	improved	63
P-01442	31%	S13	CR-01	improved	61
P-01696	30%	S20	CR-01	improved	59